Muhamad: Directing Groundbreaking Glioma Research
Muhamad, a molecular cancer researcher and stage IV lymphoma survivor, directs a glioma research program.
This program investigates the mechanisms driving tumor invasion, therapy resistance, and precision biomarker discovery in aggressive brain cancers, including glioblastoma (GBM).
The research aims to have a significant translational and population-relevant impact.